BDMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as BDMDW
Baird Medical Investment Holdings Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 24, 2026
$0.44−0.13 (-22.97%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.0840 (−71.32%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Baird Medical Investment Holdings Ltd saw revenue fall 39.2% to $22.54M over fiscal 2025. Operating income fell 267.4% to -$25.63M, moving the operating margin from 41.4% to -113.7%. Free cash flow was -$1.39M.
Revenue
$22.54M
-39.2% vs. a year earlier
Operating income
-$25.63M
-267.4% vs. a year earlier
Free cash flow
-$1.39M
FY2025
EPS, diluted
-$0.98
-271.9% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $22.54M
- Net income
- -$27.28M
- EPS, diluted
- -$0.98
- Free cash flow
- -$1.39M
Five years at a glance
Fiscal years 2021 to 2025, USD
Revenue
$22.54M-39.2% YoY
Gross profit
$18.88M-42.2% YoY
Operating income
-$25.63M-267.4% YoY
Net income
-$27.28M-319.0% YoY
EPS, diluted
-$0.98-271.9% YoY
Free cash flow
-$1.39M
Reported period